Detailed information for compound 626389

Basic information

Technical information
  • TDR Targets ID: 626389
  • Name: N-[[5-[2-[(4-acetylphenyl)amino]-2-oxoethyl]s ulfanyl-1,3,4-oxadiazol-2-yl]methyl]benzamide
  • MW: 410.446 | Formula: C20H18N4O4S
  • H donors: 2 H acceptors: 5 LogP: 1.99 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(Nc1ccc(cc1)C(=O)C)CSc1nnc(o1)CNC(=O)c1ccccc1
  • InChi: 1S/C20H18N4O4S/c1-13(25)14-7-9-16(10-8-14)22-17(26)12-29-20-24-23-18(28-20)11-21-19(27)15-5-3-2-4-6-15/h2-10H,11-12H2,1H3,(H,21,27)(H,22,26)
  • InChiKey: JAEPLMZEMAOPNC-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N-[[5-[2-[(4-acetylphenyl)amino]-2-oxo-ethyl]sulfanyl-1,3,4-oxadiazol-2-yl]methyl]benzamide
  • N-[[5-[[2-[(4-acetylphenyl)amino]-2-oxoethyl]thio]-1,3,4-oxadiazol-2-yl]methyl]benzamide
  • N-[[5-[[2-[(4-acetylphenyl)amino]-2-keto-ethyl]thio]-1,3,4-oxadiazol-2-yl]methyl]benzamide
  • N-[[5-[2-[(4-ethanoylphenyl)amino]-2-oxo-ethyl]sulfanyl-1,3,4-oxadiazol-2-yl]methyl]benzamide
  • ZINC05107272

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Entamoeba histolytica hypothetical protein 0.0036 0.6459 1
Giardia lamblia Endonuclease/Exonuclease/phosphatase 0.0018 0 0.5
Entamoeba histolytica hypothetical protein 0.0036 0.6459 1
Schistosoma mansoni transcription factor LCR-F1 0.0036 0.6459 0.6459
Trichomonas vaginalis ap endonuclease, putative 0.0018 0 0.5
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0046 1 1
Toxoplasma gondii exonuclease III APE 0.0018 0 0.5
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.0018 0 0.5
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.0018 0 0.5
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0046 1 1
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.0018 0 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0046 1 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0046 1 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0046 1 1
Treponema pallidum exodeoxyribonuclease (exoA) 0.0018 0 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0046 1 1
Entamoeba histolytica hypothetical protein 0.0036 0.6459 1
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0018 0 0.5
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0036 0.6459 0.6459
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.0018 0 0.5
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.0018 0 0.5
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.0018 0 0.5
Brugia malayi hypothetical protein 0.0036 0.6459 0.6459
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0018 0 0.5
Schistosoma mansoni hypothetical protein 0.0036 0.6459 0.6459
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0036 0.6459 0.6459
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0046 1 1
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.0018 0 0.5
Entamoeba histolytica hypothetical protein 0.0036 0.6459 1
Trichomonas vaginalis ap endonuclease, putative 0.0018 0 0.5
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0046 1 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.